Literature DB >> 32045899

Cerenkov luminescence and PET imaging of 90Y: capabilities and limitations in small animal applications.

Gregory S Mitchell1, P N Thomas Lloyd, Simon R Cherry.   

Abstract

The in vivo sensitivity limits and quantification performance of Cerenkov luminescence imaging have been studied using a tissue-like mouse phantom and 90Y. For a small, 9 mm deep target in the phantom, with no background activity present, the Cerenkov luminescence 90Y detection limit determined from contrast-to-noise ratios is 10 nCi for a 2 min exposure with a sensitive CCD camera and no filters. For quantitative performance, the values extracted from regions of interest on the images are linear within 5% of a straight line fit versus target activity for target activity of 70 nCi and above. The small branching ratio to decay with positron emission for 90Y also permits low-statistics PET imaging of the radionuclide. For PET imaging of the same phantom, with a small animal LSO detector-based scanner, the 90Y detection limit is approximately 3 orders of magnitude higher at 10 µCi.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32045899      PMCID: PMC7485541          DOI: 10.1088/1361-6560/ab7502

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  44 in total

1.  Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner.

Authors:  Jonathan A Disselhorst; Maarten Brom; Peter Laverman; Cornelius H Slump; Otto C Boerman; Wim J G Oyen; Martin Gotthardt; Eric P Visser
Journal:  J Nucl Med       Date:  2010-03-17       Impact factor: 10.057

2.  Spatial resolution and sensitivity of the Inveon small-animal PET scanner.

Authors:  Eric P Visser; Jonathan A Disselhorst; Maarten Brom; Peter Laverman; Martin Gotthardt; Wim J G Oyen; Otto C Boerman
Journal:  J Nucl Med       Date:  2009-01       Impact factor: 10.057

3.  In vivo localization of ⁹⁰Y and ¹⁷⁷Lu radioimmunoconjugates using Cerenkov luminescence imaging in a disseminated murine leukemia model.

Authors:  Ethan R Balkin; Aimee Kenoyer; Johnnie J Orozco; Alexandra Hernandez; Mazyar Shadman; Darrell R Fisher; Damian J Green; Mark D Hylarides; Oliver W Press; D Scott Wilbur; John M Pagel
Journal:  Cancer Res       Date:  2014-09-26       Impact factor: 12.701

Review 4.  Luminescence-based Imaging Approaches in the Field of Interventional Molecular Imaging.

Authors:  Fijs W B van Leeuwen; James C H Hardwick; Arian R van Erkel
Journal:  Radiology       Date:  2015-07       Impact factor: 11.105

5.  Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model.

Authors:  Robbie Robertson; Melissa Saylor Germanos; Mark G Manfredi; Peter G Smith; Matthew D Silva
Journal:  J Nucl Med       Date:  2011-10-12       Impact factor: 10.057

6.  Feasibility study of novel endoscopic Cerenkov luminescence imaging system in detecting and quantifying gastrointestinal disease: first human results.

Authors:  Hao Hu; Xin Cao; Fei Kang; Min Wang; Yenan Lin; Muhan Liu; Shujun Li; Liping Yao; Jie Liang; Jimin Liang; Yongzhan Nie; Xueli Chen; Jing Wang; Kaichun Wu
Journal:  Eur Radiol       Date:  2015-01-11       Impact factor: 5.315

7.  Performance evaluation of an Inveon PET preclinical scanner.

Authors:  Cristian C Constantinescu; Jogeshwar Mukherjee
Journal:  Phys Med Biol       Date:  2009-04-21       Impact factor: 3.609

Review 8.  Cerenkov luminescence imaging (CLI) for image-guided cancer surgery.

Authors:  M R Grootendorst; M Cariati; A Kothari; D S Tuch; A Purushotham
Journal:  Clin Transl Imaging       Date:  2016-05-24

Review 9.  Cerenkov luminescence imaging: physics principles and potential applications in biomedical sciences.

Authors:  Esther Ciarrocchi; Nicola Belcari
Journal:  EJNMMI Phys       Date:  2017-03-11

10.  Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization.

Authors:  Mattijs Elschot; Bart J Vermolen; Marnix G E H Lam; Bart de Keizer; Maurice A A J van den Bosch; Hugo W A M de Jong
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more
  1 in total

1.  Ultrasmall Porous Silica Nanoparticles with Enhanced Pharmacokinetics for Cancer Theranostics.

Authors:  Carolina A Ferreira; Shreya Goel; Emily B Ehlerding; Zachary T Rosenkrans; Dawei Jiang; Tuanwei Sun; Eduardo Aluicio-Sarduy; Jonathan W Engle; Dalong Ni; Weibo Cai
Journal:  Nano Lett       Date:  2021-05-24       Impact factor: 12.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.